Answers are grounded in this paper and cite their sources.
BACKGROUND: Ga-PSMA-11 PET/CT and to analyze the impact of CTU on assigning focal tracer accumulation in the ureteric space to either ureteric excretion or metastatic disease concerning topographic attribution and diagnostic confidence. METHODS: Ga-PSMA-11 PET/CT without and with CTU. Diagnostic confidence was evaluated using the following score: 0, < 25% confidence; 1, 26-50%; 2, 51-75%; 3, 76-100%. RESULTS: Ga-PSMA-11 PET/CT without and with CTU (n.s). CONCLUSIONS: Ga-PSMA-11 PET/CT is feasible and increases diagnostic confidence of assigning focal areas of tracer accumulation in the ureteric space to either metastatic disease or ureteric excretion.
No takes yet. Share an insight, caveat, or question.
Will et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: